Expansion Revealing of Pathology Resolves Nanostructures Associated with Inflammatory Phenotypes in COVID-19 Decedent Human Brain Tissue

This study introduces adapted expansion microscopy protocols (ExRPath and 15ExMPath) compatible with human pathology specimens to achieve high-resolution imaging of COVID-19 decedent brain tissue, revealing periodic amyloid nanoclusters co-localized with SARS-CoV-2 that suggest a novel neuroinflammatory disease mechanism.

The Gist

Imagine trying to look at a crowded city street from a helicopter. From high up, you can see the buildings and the general flow of traffic, but you can't make out the faces of the people or the specific details of the cars. This is what scientists often face when looking at human brain tissue under a microscope: the cells and proteins are packed so tightly together that they look like a blurry, indistinguishable mass.

To solve this, researchers developed a new way to "zoom in" without needing a better lens. They call it Expansion Revealing of Pathology (ExRPath).

Here is how it works, using a simple analogy:

The "Stretchy Fabric" Trick
Think of the brain tissue not as a solid rock, but as a very dense, tangled piece of fabric. Normally, if you try to pull the threads apart to see what's woven inside, the fabric tears or the threads snap because they are glued together by the chemicals used to preserve the tissue for medical exams.

The scientists created a special new recipe (ExRPath) that acts like a gentle, magical solvent. It allows them to soak the preserved brain tissue in a gel that acts like a stretchy rubber band. When they pull on this rubber band, the tissue expands 20 times in every direction.

• Before: Imagine a crowded room where everyone is shoulder-to-shoulder. You can't see who is standing next to whom.
• After: Now, imagine that same room suddenly expands so that everyone is 20 feet apart. Suddenly, you can clearly see exactly who is standing next to whom, what they are holding, and how they are interacting.

What They Found in the "Crowded Room"
The researchers used this new stretching technique on brain tissue from people who passed away from COVID-19. Because they could finally see the tiny details (down to the size of a virus), they discovered something surprising in a few of the patients:

They found tiny, repeating clusters of a protein called amyloid (which is often associated with brain inflammation) sitting right next to the SARS-CoV-2 virus.

The Big Picture
Think of it like finding a specific type of graffiti (the amyloid) painted directly on top of a specific brand of delivery truck (the virus) in a few specific neighborhoods. This doesn't happen everywhere, but when it does, it suggests a specific pattern of inflammation in the brain that might be linked to the virus.

Why This Matters
The main achievement here isn't just finding these clusters; it's proving that we can use this "stretchy" microscope trick on old, preserved medical samples that were previously impossible to study this closely. It's like taking a dusty, locked archive of old photos and suddenly being able to read the tiny handwriting on the back of them, revealing new clues about how the disease affects the brain.

In short, the paper says: "We invented a way to stretch preserved brain tissue so we can see the tiny details clearly, and in doing so, we spotted a specific link between the COVID-19 virus and brain inflammation in some patients."

Technical Summary

Technical Summary

Problem
Expansion revealing (ExR) is a technique designed to elucidate cellular organization by physically separating proteins within dense nanostructures via a 20-fold linear expansion, thereby enabling super-resolution imaging. However, a critical limitation of standard ExR is its reliance on fixation procedures that are incompatible with formalin-fixed, paraffin-embedded (FFPE) human pathology specimens. This incompatibility has prevented the application of ExR to archived clinical tissues, specifically hindering the investigation of nanostructural changes in human brain pathology.

Methodology
To overcome these limitations, the authors developed Expansion Revealing of Pathology (ExRPath). This protocol adapts the iterative 20x expansion process to be compatible with human brain pathology specimens, achieving a resolution of approximately 20 nm and enabling the "decrowding" of dense tissue structures. Additionally, the authors introduced a streamlined, single-shot protocol termed 15x Expansion of Pathology (15ExMPath), which achieves a 15x linear expansion in a single step. Both methods were specifically optimized for use on FFPE human brain tissue.

Key Contributions and Results
The authors applied ExRPath and 15ExMPath to brain tissue obtained from decedents who died with COVID-19. The high-throughput nanoimaging capabilities of these expanded protocols revealed specific structural findings:

• The identification of periodic amyloid nanoclusters within the tissue.
• Observation that these nanoclusters co-localize with SARS-CoV-2 in a rare minority of the patient specimens examined.

Significance
The paper posits that these findings point to a potential neuroinflammatory phenotype associated with COVID-19. The authors highlight the significance of their work in demonstrating the power of expansion microscopy, when adapted for high-throughput nanoimaging of clinical specimens, to uncover potential novel disease mechanisms that were previously inaccessible due to the resolution limits of conventional pathology and the incompatibility of standard expansion protocols with archived human tissues.